Insider Transactions in Q3 2025 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 02
2025
|
David V Elkins EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
56,000
-25.07%
|
$2,632,000
$47.33 P/Share
|
|
Sep 01
2025
|
Bartie Wendy Short EVP, Corporate Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
632
-10.03%
|
$29,704
$47.18 P/Share
|
|
Sep 01
2025
|
Bartie Wendy Short EVP, Corporate Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
1,235
+16.39%
|
-
|
|
Aug 02
2025
|
Bartie Wendy Short EVP, Corporate Affairs |
SELL
Open market or private sale
|
Direct |
378
-6.94%
|
$16,632
$44.23 P/Share
|
|
Aug 02
2025
|
Bartie Wendy Short EVP, Corporate Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
738
+11.94%
|
-
|
|
Aug 01
2025
|
Cari Gallman EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
543
-5.79%
|
$23,892
$44.23 P/Share
|
|
Aug 01
2025
|
Cari Gallman EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,061
+10.16%
|
-
|